Regulatory status: For research use only, not for use in diagnostic procedures.

Write a review

serum, plasma
Species Reactivity
Intended Use
Cytomegalovirus(CMV) IgG Antibody EIA Test Kit has been designed for semi-quantitative and qualitative determination of specific IgG antibodies against CMV in serum and plasma. This assay is intended for in-vitro diagnostic use only.
Contents of Kit
1. Microwell plate
2. Negative control
3. Positive control
4. Enzyme conjugate
5. TMB substrate solution
6. Stop solution
7. Sample diluent
8. Wash buffer
9. Plate lid
For more detailed information, please download the following document on our website.
Performance Characteristics
Clinical evaluation was conducted comparing the results obtained using Cytomegalovirus Antibody ELISA IgG Assay to a predicate device. The study included 163 serum samples from Russia, Ukraine, Togo, United States, and Northern Europe. 77 samples were identified as negative and 86 samples were identified as positive.
Out of the 77 negative samples, 57 samples were retrived from paitents who had previously been CMV inoculated.

The results yielded a Specificity of 100% and a Sensitivity of 89.5%.
Intra-assay-Precision: 2-7%
Inter-assay-Precision: 2-8%
Inter-Lot-Precision: 3-11%
Serological Sensitivity: 100%
General Description
Cytomegalovirus (CMV) is a DNA virus herpes virus group. Widely distributed, other animals can be infected, causing the genitourinary system, central nervous system and liver disorders of various systems based infections, from mild asymptomatic infection until the serious defects or death. Cytomegalovirus also known as virus inclusion body cells, swelling of the infected cells and nuclear inclusion bodies with huge, hence the name.

CMV has the typical form of herpes virus, the HSV DNA structure and similar, but 5% larger than the HSV. The virus on the host or cultured cells with a high degree of species specificity, human cytomegalovirus (HCMV) can infect humans, and the proliferation of cells in the human fiber. The proliferation of the virus in cell culture slow replication cycle length, first isolated and cultured 30 to 40 days appear to be cenotaphic, characterized by rounded cell swelling, nuclear becomes larger, the nucleus around which a round there, "halo" of large addicted acid inclusions.
CMV infection can affect the host organism in various organs and systems, but few opportunities for serious disease, target organ damage and with the children's age. Central nervous system damage (such as microcephaly, mental retardation, etc.) and congenital malformations were mainly seen in congenital infections; hepatitis, pneumonia can also be seen in infants and young children during infection. Therefore, infection after birth has been found in children with central nervous system damage and congenital malformations, be classified as caused by CMV infection is unscientific.

Of symptomatic CMV infection such as pneumonia, hepatitis diagnosis, rely solely on serology or urine, blood, positive results in the virological examination irregularities. The performance of these test results because the body can only exist with CMV or copied, but no orientation significance. Such as from lung disease, liver tissue in situ testing positive then, for the reliable, but the implementation difficulties. Thus, children with pneumonia should be taken to replace the lower respiratory tract secretions can cause the same disease or exclude other causes and pathogens, and strive to diagnose and reliable.


Have you cited DEIA401 in a publication? Let us know and earn a reward for your research.

Customer Reviews

Write a review, share your experiences with others and get rewarded !
Product Name Cat. No. Applications Host Species Datasheet Price Add to Basket
Product Name Cat. No. Applications Host Species Datasheet Price Add to Basket


Itzhaki, RF; et al. Herpes simplex virus type 1 and Alzheimer's disease: increasing evidence for a major role of the virus. FRONTIERS IN AGING NEUROSCIENCE 6:-(2014).
Gubensek, J; Buturovic-Ponikvar, J; et al. Plasma Exchange and Intravenous Immunoglobulin in the Treatment of Antibody-Mediated Rejection After Kidney Transplantation: A Single-Center Historic Cohort Study. TRANSPLANTATION PROCEEDINGS 45:1524-1527(2013).

Online Inquiry

Phone: *
E-mail Address: *
Technology Interest:
Type of Organization:
Service & Products Interested: *
Project Description:
Verification code
Click image to refresh the verification code.

Online Inquiry

  Interested in larger quantities ? request a quote!
  Protocol may be improved. Please feel free to contact us to obtain the latest version.!

Ordering Information

Payment methods we support:
Invoice / Purchase Order
Credit card

OUR PROMISE TO YOU Guaranteed product quality expert customer support

Inquiry Basket